title: Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.
abstract: This case report shows for the first time the usefulness of positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) in the diagnosis of primary non Hodgkin's lymphoma of the liver. Results of FDG-PET, which in contrast to other imaging techniques offers the advantage of screening the whole body, demonstrated a high glycolytic activity of a solitary mass in the liver with central necrosis (loss of glycolytic activity), but no spread of lymphoma to the body. These results were confirmed by ultrasound, computed tomography, magnetic resonance imaging and were biopsy proven. From our findings we conclude that in patients with liver masses with high uptake of FDG, lack of liver dysfunction and absence of signs indicating other malignancies, a primary lymphoma of the liver should be considered as a possible diagnosis.
authors.affiliation: Department of Internal Medicine III, University of Ulm, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Bangerter
authors.forename: F
authors.initials: F
authors.lastname: Moog
authors.forename: M
authors.initials: M
authors.lastname: Griesshammer
authors.forename: E
authors.initials: E
authors.lastname: Merkle
authors.forename: M
authors.initials: M
authors.lastname: Hafner
authors.forename: V
authors.initials: V
authors.lastname: Ellenrieder
authors.forename: S N
authors.initials: SN
authors.lastname: Reske
authors.forename: H
authors.initials: H
authors.lastname: Heimpel
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging*; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging*; D008875:Middle Aged; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18